Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma
Clinical trial NCT02163057 · COMPLETED
Trial details
- NCT number
- NCT02163057
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-13
- Primary completion
- 2017-01-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.